Viana, V.G. (2026) “ORAL GLP-1 RECEPTOR AGONIST (ORFORGLIPRON) IN THE MANAGEMENT OF OBESITY AND TYPE 2 DIABETES”, Seven Editora, pp. 43–55. Available at: https://sevenpubl.com.br/editora/article/view/8968 (Accessed: 4 March 2026).